News + Events

Renowned cardiac researcher and educator Dr. Victor Dzau visits Vancouver

Posted: 11 January, 2012

Back to News

Renowned cardiac researcher and educator Dr. Victor Dzau will visit Vancouver on February 6, 2012. Dr. Dzau is Chancellor for Health Affairs at Duke University, and President and CEO of the Duke University Health System. He is also James B. Duke Professor of Medicine and director of molecular and genomic vascular biology.

Before coming to Duke, Dzau was the Hersey Professor of the Theory and Practice of Physic (Medicine) at Harvard Medical School, and held the positions of chairman of the Department of Medicine, and physician-in-chief and director of research at Brigham and Women’s Hospital, Boston. Prior to this, he served as Arthur Bloomfield Professor and chairman of the Department of Medicine at Stanford University.

Along with many other awards, Dr. Dzau won the prestigious 2011 Henry G. Friesen International Prize in Health Research for his outstanding achievement in fundamental and clinical cardiovascular research, for innovations in medical education, and for compassionate leadership in global health.

Dzau’s academic interests are in cardiovascular translational research and mission-based education. He pioneered gene therapy for vascular disease, being the first to introduce DNA decoy molecules to block transcriptions as gene therapy in vivo. Two of his discoveries, E2F decoy and nitric oxide synthase gene therapy, are now being evaluated in clinical trials.

While in Vancouver, Dr. Dzau will participate in the forum on Stem Cells and Regenerative Medicine for Cardiac Care at St. Paul’s Hospital at St. Paul’s Hospital, and the forum on Global Health at the UBC Life Sciences Centre.